Usefulness of the laser‐cut, fully covered, self‐expandable metallic stent for endoscopic ultrasound‐guided hepaticogastrostomy

Authors:

Abstract
Background/Purpose: Endoscopic ultrasound‐guided hepaticogastrostomy (EUS‐HGS) has many associated adverse events. We evaluated the clinical efficacy and safety of the laser‐cut, fully covered, self‐expandable metallic stent (FCSEMS) for this procedure.Methods: This single‐center, retrospective study included cases where EUS‐HGS with a laser‐cut FCSEMS was performed for malignant biliary obstruction. Technical and clinical success, time to recurrent biliary obstruction (TRBO), procedure time, adverse events, and re‐interventions were evaluated.Results: There were 95 eligible cases. Technical and clinical success rates were 100.0% and 95.8%, respectively. Median TRBO was 398 days. RBO causes were hyperplasia (7.4%), debris (3.2%), and migration (4.2%). Adverse events occurred in nine cases (9.5%). Non‐occlusion and focal cholangitis occurred in four cases (4.2%) each. Nineteen patients (20%) underwent combined EUS‐HGS (CH) procedures: antegrade stenting, bridging methods, plastic stent anchoring in SEMS, and EUS‐hepaticoduodenostomy. The solely EUS‐HGS (SH) group had significantly longer median TRBO than the CH group (398 vs 246 days, P = .04). There were no significant differences in adverse events between the two groups. Re‐intervention was performed in 29 cases (technical success rate: 100.0%).Conclusions: Laser‐cut FCSEMS can be safely placed in the bile duct and easily applied during re‐intervention, making it useful in EUS‐HGS.
Funding Information
  • National Cancer Center Japan

This publication has 26 references indexed in Scilit: